Aily Labs Expands Board with Industry Leaders

Aily Labs has announced the expansion of its board and advisory board with the addition of prominent industry figures Amy Chang, Joseph Jimenez, and Derica Rice, announced in a press release. This strategic move aims to accelerate the adoption of agentic AI across Fortune 500 companies.

Amy Chang, known for her roles on the boards of Disney and Procter & Gamble, joins Aily Labs' Board of Directors and Advisory Board. Her experience in digital transformation and technology scaling is expected to drive innovation at Aily Labs. Joseph Jimenez, co-founder of Aditum Bio and former CEO of Novartis, brings his expertise in healthcare and strategic growth to the advisory board. Derica Rice, with his extensive background in healthcare and finance from roles at CVS Health and Eli Lilly, also joins the advisory board.

These appointments are part of Aily Labs' mission to reshape enterprise decision-making through its AI-native Decision Intelligence App, which provides real-time insights and actionable data to enhance efficiency and innovation for global enterprises.